USPTO serial 79458018
DARWIN BIOTECH
Reviewed by CopyMark Law Group
Status 640Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- HUSSAIN, TASNEEM
- Law office
- TMO LAW OFFICE 118
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with DARWIN BIOTECH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Reagent paper for medical purposes; pharmaceutical preparations for the treatment of neurodegeneration; preparations of microorganisms for medical purposes; cultures of microorganisms for medical or veterinary use; pharmaceutical preparations for the treatment of Amyotrophic lateral sclerosis; pharmaceutical preparations for the central nervous system; pharmaceutical preparations for wounds; medicines for the treatment of cardiovascular and cerebrovascular diseases; biological tissue cultures for medical purposes; stem cells for medical purposes. | ACTIVE | — |
| 010 | Medical apparatus and instruments for treating cardiovascular disease; manually-operated exercise equipment for physical therapy purposes; massage apparatus [for medical purposes]; apparatus for the regeneration of stem cells for medical purposes; nerve stimulator apparatus; surgical implants comprising artificial material. | ACTIVE | — |
| 035 | Advertising services; organization of exhibitions for commercial or advertising purposes; updating of advertising material; online advertising on a computer network; production of advertising films; sales promotion for others; wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; demonstration of goods; business management consultancy; negotiation and conclusion of commercial transactions for third parties. | ACTIVE | — |
| 042 | Cell free protein synthesis technology research; biochemical research and analysis; development of pharmaceutical preparations and medicines; research and development of new products; product safety testing services; scientific investigation for medical purposes; chemical research and analysis; DNA screening for scientific research purposes; research of induced pluripotent stem cells; stem cell research services. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Darwin Biotechnology (Hubei) Co., Ltd.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named DARWIN BIOTECH
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 8, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 7, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 6, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 5, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 5, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 5, 2026 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Sep 10, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |